/cloudfront-us-east-2.images.arcpublishing.com/reuters/U5VZBBJ5SBJARD5TTCJHHDF6VM.jpg "FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study")
by admin | Nov 5, 2023 | News & Opinions
By Reuters News Oct 31 (Reuters) – A panel of advisers to the U.S. health regulator said on Tuesday Vertex Pharmaceuticals (VRTX.O) and CRISPR Therapeutics (CRSP.BN) could assess potential safety risks of their sickle cell disease gene therapy after approval. If...
by admin | Nov 3, 2023 | News & Opinions
By Japan Times A Japanese medical institution, in a first for the country, will seek government approval for using embryonic stem cells as a regenerative medicine product to treat babies with a severe liver ailment, sources close to the matter said Monday. The step...
by admin | Nov 2, 2023 | News & Opinions
By Kyushu University Fukuoka, Japan – Researchers at Kyushu University have discovered that turning brain immune cells into neurons successfully restores brain function after stroke-like injury in mice. These findings, published on October 10 in PNAS, suggest that...
by admin | Nov 1, 2023 | News & Opinions
by Arkadi Mazin – Lifespan.io The need for a paradigm shift Last August, hundreds of longevity enthusiasts, from certified geroscience stars to graduate students, gathered in Dublin for the annual Longevity Summit conference. As the attendants were enjoying the...
by admin | Oct 31, 2023 | News & Opinions
By Antonio Regalado – MIT Technology Review The gene-editing technology CRISPR has been used to change the genes of human babies, to modify animals, and to treat people with sickle-cell disease. Now scientists are attempting a new trick: using CRISPR to...
by admin | Oct 30, 2023 | News & Opinions
By UMass Chan Medical School The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing...
